FBN1 rs121908077: Understanding This Genetic Variant
The rs121908077 variant is a specific change located within the FBN1 gene, which provides instructions for making a protein essential for connective tissue. This variant has been studied for its potential role in increasing susceptibility to thoracic aortic aneurysms and various ocular or skeletal features associated with Marfan syndrome.
What each genotype means
Typical FBN1 profile
This genotype represents the common, non-variant form of the FBN1 gene at this location. It is not associated with the increased susceptibility to Marfan syndrome or related connective tissue disorders linked to this specific variant.
This is the most common genotype found in the general population.
Increased susceptibility profile
This genotype indicates the presence of the variant allele, which has been associated with an increased susceptibility to thoracic aortic aneurysms and ocular or skeletal features characteristic of Marfan syndrome. Because Marfan syndrome is typically inherited in an autosomal dominant manner, individuals with this variant should consult with a medical geneticist or cardiologist to discuss clinical screening and monitoring.
This specific genotype is extremely rare, with a global minor allele frequency reported as less than 0.00001 in large population databases.
Increased susceptibility profile
This genotype indicates the presence of two copies of the variant allele. It is associated with an increased susceptibility to thoracic aortic aneurysms and features of Marfan syndrome, and individuals with this result should discuss the findings with a healthcare professional for appropriate clinical evaluation and management.
This genotype is exceptionally rare in the general population.
What is the rs121908077 Variant?
The rs121908077 variant is a specific alteration in the DNA sequence of the FBN1 gene. In genetics, a single nucleotide polymorphism (SNP) or variant represents a change at a single position in the genetic code. This particular variant is located within the FBN1 gene, which is situated on chromosome 15. The FBN1 gene is responsible for encoding fibrillin-1, a large, cysteine-rich protein that is a major component of microfibrils in the extracellular matrix. These microfibrils provide structural support to tissues throughout the body, including the walls of blood vessels, the eyes, and the skeleton. When a variant occurs in this gene, it may alter the structure or function of the fibrillin-1 protein, potentially impacting the integrity of connective tissues. Researchers track these variants to understand how specific changes in the genetic blueprint correlate with physical traits or health conditions.
The Role of the FBN1 Gene
The FBN1 gene is critical for maintaining the structural integrity of connective tissues. Fibrillin-1 proteins assemble into microfibrils, which not only provide physical scaffolding for tissues but also act as a reservoir for growth factors, such as transforming growth factor-beta (TGF-beta). By regulating the availability of these growth factors, fibrillin-1 plays a key role in tissue development and repair. Mutations or variants in FBN1 can disrupt this delicate balance, leading to a group of disorders known as fibrillinopathies. These conditions, including Marfan syndrome, are characterized by a wide range of clinical manifestations. Because the FBN1 gene is expressed in many different parts of the body, variants can lead to diverse symptoms, such as aortic root dilation, lens dislocation in the eye, and skeletal overgrowth. Understanding the function of this gene is essential for interpreting how specific variants might influence health outcomes.
Research and Evidence Strength
Current research into rs121908077 indicates that its association with clinical conditions is considered to have limited evidence. In the field of clinical genetics, variants are often classified based on the strength of evidence linking them to specific diseases. While many FBN1 variants are well-documented as pathogenic, others remain classified as variants of uncertain significance (VUS) until more data is collected. Studies often rely on large cohorts and clinical observation to determine if a variant is truly causative. For rs121908077, the evidence suggests a potential link to thoracic aortic aneurysms and Marfan-like features, but it does not automatically imply a diagnosis. Because Marfan syndrome and related disorders are complex, clinical diagnosis is typically based on a combination of physical examinations, family history, and imaging, rather than the presence of a single genetic variant alone.
Population Frequency
The rs121908077 variant is extremely rare in the general population. According to data from the Genome Aggregation Database (gnomAD), the global minor allele frequency (MAF) for this variant is less than 0.00001. This low frequency indicates that the variant is not commonly found in the general public, which is typical for variants associated with rare, inherited connective tissue disorders. Because it is so rare, large-scale population studies have limited data on its distribution across different ancestral groups. When a variant is this uncommon, it is often identified through clinical testing of individuals who are already presenting with symptoms, rather than through population-wide screening. The rarity of the variant underscores the importance of consulting with a genetic counselor or medical specialist if this variant is identified in a clinical report, as they can provide context based on individual health history.
Navigating Genetic Information
If you have received information about the rs121908077 variant, it is important to approach it with a clear understanding of what genetic testing can and cannot tell you. A genetic variant is not a medical diagnosis; it is simply a piece of information about your DNA. Because the evidence for this specific variant is limited, its presence does not necessarily mean that an individual will develop a specific health condition. Genetic information should always be interpreted by a qualified healthcare professional, such as a medical geneticist or a genetic counselor, who can integrate the findings with your personal and family medical history. You should never make medical decisions or changes to your health management based solely on a genetic report. Always discuss your results with your clinician to determine if any follow-up, such as cardiovascular screening or specialized monitoring, is appropriate for your specific situation.
How common is this variant?
The rs121908077 variant is extremely rare, with a global minor allele frequency of less than 0.00001 according to gnomAD.
Frequently asked questions
Does having the rs121908077 variant mean I have Marfan syndrome?
No, identifying a single genetic variant does not constitute a diagnosis of Marfan syndrome. Diagnosis is a clinical process that involves evaluating physical symptoms, family history, and imaging results by a medical specialist.
What should I do if my genetic report mentions this variant?
You should schedule an appointment with a genetic counselor or a cardiologist who specializes in connective tissue disorders. They can help you understand the significance of the finding in the context of your personal health.
Why is the evidence for this variant considered limited?
Evidence is considered limited when there is not enough published research or clinical data to definitively classify the variant as pathogenic or benign. This is common for rare variants where few cases have been documented.
Is this variant common in my ancestry?
The variant is extremely rare across all populations studied in databases like gnomAD. It is not known to be more common in any specific ancestral group.
Sources & further reading
Educational information only, last refreshed 9/26/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs121908077?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29